The global portable and wearable dialysis devices market is expected to reach US$ 4,393.8 million by 2027 from US$ 3,023.1 million in 2019; it is estimated to grow at a CAGR of 5.0% from 2020 to 2027.
Increasing number of ESRD patients and limited availability of organ donors are key factors driving the portable and wearable dialysis devices market. However, reimbursement concerns in emerging market and technical challenges associated with WAK and WDD development are the major factors hindering the market growth.
As per the data provided by National Kidney Foundation Inc., currently, 100,000 people in the US are on the national transplant waiting list for donors' kidneys. Every 10 minutes, one person is added to the national transplant waiting list, and 82% of patients need a kidney. Moreover, 13 people die each day while waiting for a life-saving kidney transplant. In 2014, 4,761 patients died while waiting for a kidney transplant. Another, 3,668 people became too sick to receive a kidney transplant. Most patients awaiting a kidney transplant survive by undergoing long and unwieldy dialysis treatments multiple times a week to clear toxins from their blood. Still, dialysis does not replace many essential kidney functions, and on average, only 35% of dialysis patients survive after five years. Dialysis and other treatments for ESRD, which are universally covered by Medicare, cost US$ 35 billion in 2016, representing 7% of Medicare's annual budget. The limited availability of donors, leading to limited transplantation, in turn increases the adoption of wearable portable devices for the treatment of renal diseases. For instance, The Kidney Project led by Roy and Vanderbilt University Medical Center for more than a decade has been working to develop an implantable bio artificial kidney to eliminate dialysis needs and ease the shortage of donor kidneys.
The global portable and wearable dialysis devices market is segmented by product type and end user. Based on type, the market is segmented into hemodialysis and peritoneal dialysis. The hemodialysis segment held a larger share of the market in 2019 and is anticipated to register a higher CAGR in the market during the forecast period. Based on end user, the portable and wearable dialysis devices market has been segmented into hospitals, clinics, and homes. The hospitals segment held the largest share of the market in 2019, whereas the home segment is estimated to register the highest CAGR during the forecast period
The National Institutes of Health (NIH), World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), American Cancer Society, Australian Institute of Health and Welfare, and Dubai Health Authority are among the essential secondary sources refereed to while preparing this report.
Reasons to Buy:
Increasing number of ESRD patients and limited availability of organ donors are key factors driving the portable and wearable dialysis devices market. However, reimbursement concerns in emerging market and technical challenges associated with WAK and WDD development are the major factors hindering the market growth.
As per the data provided by National Kidney Foundation Inc., currently, 100,000 people in the US are on the national transplant waiting list for donors' kidneys. Every 10 minutes, one person is added to the national transplant waiting list, and 82% of patients need a kidney. Moreover, 13 people die each day while waiting for a life-saving kidney transplant. In 2014, 4,761 patients died while waiting for a kidney transplant. Another, 3,668 people became too sick to receive a kidney transplant. Most patients awaiting a kidney transplant survive by undergoing long and unwieldy dialysis treatments multiple times a week to clear toxins from their blood. Still, dialysis does not replace many essential kidney functions, and on average, only 35% of dialysis patients survive after five years. Dialysis and other treatments for ESRD, which are universally covered by Medicare, cost US$ 35 billion in 2016, representing 7% of Medicare's annual budget. The limited availability of donors, leading to limited transplantation, in turn increases the adoption of wearable portable devices for the treatment of renal diseases. For instance, The Kidney Project led by Roy and Vanderbilt University Medical Center for more than a decade has been working to develop an implantable bio artificial kidney to eliminate dialysis needs and ease the shortage of donor kidneys.
The global portable and wearable dialysis devices market is segmented by product type and end user. Based on type, the market is segmented into hemodialysis and peritoneal dialysis. The hemodialysis segment held a larger share of the market in 2019 and is anticipated to register a higher CAGR in the market during the forecast period. Based on end user, the portable and wearable dialysis devices market has been segmented into hospitals, clinics, and homes. The hospitals segment held the largest share of the market in 2019, whereas the home segment is estimated to register the highest CAGR during the forecast period
The National Institutes of Health (NIH), World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), American Cancer Society, Australian Institute of Health and Welfare, and Dubai Health Authority are among the essential secondary sources refereed to while preparing this report.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the portable and wearable dialysis devices market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global percutaneous mechanical circulatory support devices market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction
3. Research Methodology
4. Portable and Wearable Dialysis Devices Market - Market Landscape
5. Portable and Wearable Dialysis Device Market - Key Market Dynamics
6. Portable and Wearable Dialysis Device Market - Global Analysis
7. Portable and Wearable Dialysis Devices Market Analysis - By Product Type
8. Portable and Wearable Dialysis Devices Market Analysis - By End User
9. Portable and Wearable Dialysis Devices Market - Geographic Analysis
10. Impact of COVID-19 Pandemic On Global Portable and Wearable Dialysis Devices Market
11. Portable and Wearable dialysis devices Market - Industry Landscape
12. COMPANY PROFILES
13. Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- ALLMED HEALTHCARE MANAGEMENT, INC.
- ASAHI KASEI CORPORATION
- AWAK TECHNOLOGIES
- B.BRAUN
- BAXTER INTERNATIONAL INC.
- FRESENIUS MEDICAL CARE AG AND CO. KGAA
- NIPRO
- Medetronic
- QUANTA DIALYSIS TECHNOLOGIES.